Results 11 to 20 of about 13,012 (251)
Unilateral laterothoracic exanthema in an adult [PDF]
Clinical Case Reports, 2020 AbstractUnilateral laterothoracic exanthema (ULE) is a benign self‐limited condition that spontaneously resolves in a few weeks. Occurring mostly in childhood, although few rare cases in adults have been also reported. Diagnosis of ULE is clinical, and laboratory investigations are not required.
Amal Chamli +3 more
openaire +4 more sources
Systemic drug‐related intertriginous and flexural exanthema like eruption after CoronaVac vaccine [PDF]
Journal of the European Academy of Dermatology and Venereology, 2021 Systemic contact dermatitis is a condition seen in individuals when sensitized to an allergen through skin then exposure to the sensitized substance or cross-reacting to it (1).
Özge Mine Örenay +3 more
openalex +2 more sources
Symmetrical Drug-related Intertriginous and Flexural Exanthema (Baboon Syndrome)
European Journal of Case Reports in Internal Medicine, 2021 Baboon syndrome, also called symmetrical drug-related intertriginous and flexural exanthema (SDRIFE), is an erythematous maculopapular rash that presents in skin folds in a symmetrical pattern.
Olinda Miranda +6 more
openalex +3 more sources
Pain and Therapy, 2022 Introduction Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE), formerly also called baboon syndrome, is characterized by symmetrical erythematous rash with typical localization in the gluteal and intertriginous areas.
C. Göbel +5 more
semanticscholar +1 more source
Symmetrical drug‐related intertriginous and flexural exanthema‐like eruption after COVID‐19 vaccine
Journal of the European Academy of Dermatology and Venereology, 2022 var-iant of BS referred as symmetrical drug-related intertriginous and flexural exanthema (SDRIFE). report two cases of SDRIFE-like eruption occurring after COVID-19 vaccine.
I. Lahouel +7 more
semanticscholar +1 more source
Clinical and Molecular Allergy, 2022 Systemic drug-related intertriginous and flexural exanthema (SDRIFE) is an adverse drug reaction which manifests as a symmetrical erythematous rash involving the skin folds after systemic drug exposure.
D. Di Bona, Andrea Miniello, E. Nettis
semanticscholar +1 more source
Clincal and Experimental Dermatology, 2021 This is a case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption following ChAdOx1 nCoV‐19 (AstraZeneca‐Oxford) vaccination. Investigations, including repeated skin swabs, ruled out an infectious cause.
P. N. Lim, G. Wylie
semanticscholar +1 more source
Journal of cutaneous pathology, 2021 Symmetric drug‐related intertriginous and flexural exanthema (SDRIFE) is a cutaneous drug reaction characterized by gluteal/anogenital erythema and symmetric involvement of other intertriginous location(s) without systemic signs.
A. Schuler +7 more
semanticscholar +1 more source
Allergy. European Journal of Allergy and Clinical Immunology, 2021 Coronavirus disease‐2019 (COVID‐19) has been associated with cutaneous findings, some being the result of drug hypersensitivity reactions such as maculopapular drug rashes (MDR).
Y. Mitamura +18 more
semanticscholar +1 more source
HLA Risk Alleles in Aromatic Antiepileptic Drug-Induced Maculopapular Exanthema
Frontiers in Pharmacology, 2021 To characterize human leukocyte antigen (HLA) loci as risk factors in aromatic antiepileptic drug-induced maculopapular exanthema (AED-MPE). A case-control study was performed to investigate HLA loci involved in AED-MPE in a southern Han Chinese ...
Yi-Wu Shi +24 more
semanticscholar +1 more source